Clinical Trial Detail

NCT ID NCT01064648
Title Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

malignant pleural mesothelioma

Therapies

Cediranib + Cisplatin + Pemetrexed Disodium

Age Groups: adult

No variant requirements are available.